Novo Nordisk (NVO) Q4 2023 Earnings Call Transcript : vimars

NVO earnings call for the period ending December 31, 2023.

Related Keywords

Denmark , United States , Kalundborg , Sjæand , France , Japan , China , Hillerod , Hovedstaden , Danish , Karsten Munk Knudsen , Doug Langa , America Merrill Lynch , Simon Baker Redburn , Inversago Pharma , Richard Parkes , Seamus Fernandez , Lilly Zepbound , Harry Sephton , Pete Verdult Citi , Richard Parkes Exane , Sachin Jain , Mark Purcell Morgan Stanley , Michael Novod , Martin Parkhoi , Daniel Muusmann Bohsen , Lars Fruergaard Jorgensen , Simon Baker , Mark Purcell , Pete Verdult , Michael Novod Nordea , Paribas Exane , Louise Chen , Mike Nedelcovych , Richard Vosser Jpmorgan , Martin Holst Lange , Redburn Atlantic , Peter Verdult , Camilla Sylvest , Daniel Bohsen , Louise Chen Cantor Fitzgerald , Richard Vosser , Seamus Fernandez Guggenheim , Head Of Development , Corporate Affairs , Nordea , Sachin Jain Bank , Barclays , Citigroup , Morgan Stanley , Company Analyst , Novo Nordisk , North America , Karsten Munk , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Vice President , Commercial Strategy , Western Ontario , Mcmaster Universities Osteoarthritis Index , Kansas City , Chief Financial , Forma Therapeutics , Enskilda Banken , Emily Field , Cantor Fitzgerald , Skandinaviska Enskilda Banken , Guggenheim Partners , Redburn Partners , Executive Vice President , Chief Executive Officer ,